ArticleFrontiers in public health2025
Global, regional, and national burden of neonatal diseases attributable to particulate matter pollution from 1990 to 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of particulate matter pollution (PMP) on neonatal health has garnered growing public attention. However, the global burden of PMP-related neonatal diseases remains insufficiently characterized. This study aimed to evaluate the current burden and temporal trends (1990-2021) of PMP-related neonatal diseases. Methods: We used data from the 2021 Global Burden of Disease Study (GBD) to estimate disability-adjusted life years (DALYs) of neonatal diseases attributed to PMP. Our analysis included DALY trends by age, gender, and sociodemographic index (SDI) from 1990 to 2021 at global, regional, and national levels. We employed health inequality analysis and frontier analysis to quantify the factors that contribute to the neonatal diseases burden attributed to PMP. Results: In 2021, the global age-standardized DALYs of neonatal diseases attributed to PMP, household air pollution (HAP), and ambient particulate matter pollution (APMP) were 723.06/100,000 (95% UI: 610.39, 845.18), 518.10/100,000 (95% UI: 410.06, 641.68), and 204.81/100,000 (95% UI: 121.31, 311.25), respectively. From 1990 to 2021, PMP- and HAP-related neonatal disease burdens declined significantly, whereas APMP-related DALYs increased in low-middle SDI regions. Age-specific DALYs showed a gradual downward trend, and male DALYs were higher than female DALYs in all age groups. DALYs of neonatal diseases attributed to PMP, HAP, and APMP were negatively correlated with SDI. Frontier analysis indicated that urgent action was required to alleviate the burden of neonatal diseases attributed to PMP in countries such as Mali, South Sudan, the Central African Republic, Sierra Leone, and Nigeria. Conclusion: The burden of neonatal disease attributed to PMP remains a major health problem worldwide, especially in low SDI regions. This suggests that future air pollution-induced neonatal disease responses should emphasize health equity. Low SDI regions should be prioritized when allocating resources to address climate change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.